Hereditary keratitis is characterized by opacification and vascularisation of the cornea, often associated with macula hypoplasia.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
The limited documentation surrounding autosomal dominant keratitis is primarily due to its rarity, which affects fewer than a few thousand individuals globally. This rarity restricts the scope of systematic clinical studies and comprehensive phenotype documentation. Additionally, the genetic basis was only recently identified, and ongoing clinical characterization is necessary to better understand the condition and its manifestations.
To navigate your journey with autosomal dominant keratitis, consider consulting with an ophthalmologist specializing in hereditary eye diseases or a geneticist with experience in genetic eye disorders. Genetic counseling may also be beneficial to understand your condition and its implications for family members. While no specific patient organizations are currently identified for this condition, you can access resources from the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for further support and information. Engaging in discussions with healthcare professionals can help identify any potential natural history studies or registries that may be available in the future.
Actionable guidance for navigating care for autosomal dominant keratitis
To navigate your journey with autosomal dominant keratitis, consider consulting with an ophthalmologist specializing in hereditary eye diseases or a geneticist with experience in genetic eye disorders. Genetic counseling may also be beneficial to understand your condition and its implications for family members. While no specific patient organizations are currently identified for this condition, you can access resources from the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for further support and information. Engaging in discussions with healthcare professionals can help identify any potential natural history studies or registries that may be available in the future.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 6, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.